Bethesda Biopharma is developing East Africa's first dedicated oncology pharmaceutical manufacturing facility to address critical cancer medicine access gaps across the region. With over 1.1 million cancer cases diagnosed annually in Africa and 90% import dependency for oncology medicines, we are building local manufacturing capacity to ensure sustainable access to essential cancer treatments.
WHO GMP-compliant oncology manufacturing facility serving East African markets, with expansion planned across the continent. Partnership-driven approach with governments, procurement agencies, and healthcare systems throughout Kenya, Uganda, Tanzania, Rwanda, Ethiopia, and the Democratic Republic of Congo. Phased development strategy starting with fill & finish operations and scaling to comprehensive API manufacturing. Regulatory pathway aligned with EAC harmonisation initiatives and international quality standards to ensure product acceptance across regional markets.
